Article Information
- Received March 29, 2004
- Revision received May 11, 2004
- Accepted May 13, 2004
- First published June 30, 2004.
- Version of record published June 30, 2004.
Author Information
- Elena Klenova1,
- Alison C. Scott2,3,
- Julian Roberts1,
- Shaharum Shamsuddin1,5,
- Elizabeth A. Lovejoy3,
- Stephan Bergmann6,
- Vivien J. Bubb3,4,
- Hans-Dieter Royer7, and
- John P. Quinn2,3
- 1Department of Biological Sciences, University of Essex, Essex CO4 3SQ, United Kingdom, 2Physiology Laboratory, Departments of 3Human Anatomy and Cell Biology and 4Neurological Science, Medical School, University of Liverpool, Liverpool L69 3BX, United Kingdom, 5School of Health Sciences, University Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia, 6Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, and 7Breast Cancer Research, Center of Advanced European Studies and Research, 53175 Bonn, Germany
Author contributions
Disclosures
- Received March 29, 2004.
- Revision received May 11, 2004.
- Accepted May 13, 2004.
This work was supported by grants from the Wellcome Trust, Biotechnology and Biological Sciences Research Council, Medical Research Council (all to J.P.Q.), and the Breast Cancer Campaign (E.K.); a PhD scholarship from the Malaysian Government (S.S.); and a PhD studentship from the University of Essex (J.R.). We are grateful to A. Lee and J. Ting for the YB-1 vector constructs and antibodies and I. Chernukhin for providing us with the purified bvCTCF samples.
Correspondence should be addressed to either of the following: Dr. John Quinn, Department of Human Anatomy and Cell Biology, Medical School, University of Liverpool, Liverpool L69 3BX, UK, E-mail: jquinn{at}liv.ac.uk; or Dr. Elena Klenova, Department of Biological Sciences, University of Essex, Wivenhoe Park, Colchester, Essex CO4 3SQ, UK, E-mail: klenovae{at}essex.ac.uk.
Copyright © 2004 Society for Neuroscience 0270-6474/04/245966-08$15.00/0
Online Impact